The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis

In the study, we analyzed role of p53 in predicting outcome in visceral metastasis breast cancer (VMBC) patients. 97 consecutive VMBC patients were studied. P53 positivity rate was 29.9%. In the p53-negative group, median disease free survival (DFS), and time from primary breast cancer diagnosis to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, P., Du, C. W., Kwan, M., Liang, S. X., Zhang, G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718193/
https://www.ncbi.nlm.nih.gov/pubmed/23873310
http://dx.doi.org/10.1038/srep02246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718193/
https://www.ncbi.nlm.nih.gov/pubmed/23873310
http://dx.doi.org/10.1038/srep02246

Ejemplares similares